scPharmaceuticals | SC 13G:超过5%持股股东披露文件-J. Luther King, Jr.(5.3%),Luther King Capital Management Corporation(5.0%)
scPharmaceuticals | 8-K:重大事件
scPharmaceuticals | 10-Q:季度报表
scPharmaceuticals | 8-K:重大事件
scPharmaceuticals | SC 13G:超过5%持股股东披露文件-Laurence W. Lytton(5.1%)
scPharmaceuticals | DEFA14A:其他
scPharmaceuticals | DEF 14A:股东委托书决议
scPharmaceuticals | PRE 14A:并购重组委托声明
scPharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(4.99%)
scPharmaceuticals | 4:持股变动声明-高管 Tucker John H
scPharmaceuticals | EFFECT:其他
scPharmaceuticals | 424B5:募资说明书
scPharmaceuticals | CORRESP:信函
scPharmaceuticals | UPLOAD:其他
scPharmaceuticals | S-8:员工福利计划证券登记
scPharmaceuticals | S-3:特定交易注册声明
scPharmaceuticals | 10-K:年度报表
scPharmaceuticals | 8-K:重大事件
scPharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Andrew J. Schwab(3.3%),5AM Partners IV, LLC(2.8%)等
scPharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Armistice Capital, LLC(0%),Steven Boyd(0%)
暂无数据